Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin Lymphoma, Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00140569
What this trial is testing

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Who this might be right for
Follicular Lymphoma
Lymphoma Study Association 400
Testing effectiveness (Phase 2)Study completedNCT02104505
What this trial is testing

Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS

Who this might be right for
Mild, Allergic Asthma
University of North Carolina, Chapel Hill 23
Not applicableStudy completedNCT06817122
What this trial is testing

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Who this might be right for
Dementia, MildMild Cognitive Impairment (MCI)
University of Washington 222
Not applicableLooking for participantsNCT05255354
What this trial is testing

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

Who this might be right for
Follicular LymphomaDiffuse Large B Cell LymphomaMantle Cell Lymphoma
Adaptive Biotechnologies 300
Testing effectiveness (Phase 2)Ended earlyNCT01549886
What this trial is testing

Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Spectrum Pharmaceuticals, Inc 5
Not applicableUnknownNCT04870853
What this trial is testing

Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy

Who this might be right for
Recurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+7 more
M.D. Anderson Cancer Center 150
Early research (Phase 1)Ended earlyNCT02454270
What this trial is testing

A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+2 more
Janssen Research & Development, LLC 59
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Not applicableStudy completedNCT02520895
What this trial is testing

Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
LYMPHOMA
Hospices Civils de Lyon 98
Large-scale testing (Phase 3)Study completedNCT01059630
What this trial is testing

Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)

Who this might be right for
Non-Hodgkin's Lymphoma
Genentech, Inc. 413
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Not applicableActive Not RecruitingNCT05713071
What this trial is testing

Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity

Who this might be right for
ObesityWeight LossDelayed Gastric Emptying Following Procedure+3 more
Brigham and Women's Hospital 20
Early research (Phase 1)WithdrawnNCT02238522
What this trial is testing

Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML

Who this might be right for
Lymphoproliferative MalignanciesAcute Myeloid Leukemia
Zenith Epigenetics
Early research (Phase 1)Study completedNCT00001572
What this trial is testing

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

Who this might be right for
B Cell LymphomaFollicular LymphomaNeoplasm
National Cancer Institute (NCI) 21
Very early researchStudy completedNCT00017381
What this trial is testing

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaContiguous Stage II Adult Diffuse Small Cleaved Cell LymphomaContiguous Stage II Grade 1 Follicular Lymphoma+47 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT02303119
What this trial is testing

Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT)

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 221
Testing effectiveness (Phase 2)Looking for participantsNCT07468136
What this trial is testing

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Who this might be right for
Anaplastic OligodendrogliomaAstrocytoma, IDH-Mutant, Grade 3Astrocytoma, IDH-Mutant, Grade 4+3 more
Mayo Clinic 33
Testing effectiveness (Phase 2)Study completedNCT01939899
What this trial is testing

Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Millennium Pharmaceuticals, Inc. 29
Early research (Phase 1)Ended earlyNCT00538187
What this trial is testing

Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma

Who this might be right for
Adult Non-Hodgkin LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00006252
What this trial is testing

Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Cancer and Leukemia Group B 47
Next Page